Ann Arbor, MI, United States of America

Harry LeVine, Iii


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Harry LeVine, III

Introduction

Harry LeVine, III, an accomplished inventor based in Ann Arbor, MI, has made significant strides in the field of biomedical innovations. With a total of four patents to his name, he has dedicated his research to understanding and addressing critical health issues, particularly those related to amyloidosis and Alzheimer’s disease.

Latest Patents

Among his notable inventions, LeVine's latest patents focus on a naphthylazo compound that inhibits amyloid aggregation in animals. This innovative approach involves administering a specially formulated compound where R1 and R2 can be hydrogen, alkyl, or substituted alkyl, with R3 being hydrogen or alkyl. The importance of this invention lies in its potential applications in preventing and treating Alzheimer’s disease, a condition that affects millions globally. Another significant patent outlines a method for imaging amyloid deposits, further contributing to advancements in medical imaging and diagnosis.

Career Highlights

Harry LeVine, III currently works at Warner-Lambert Company, where he continues to push the boundaries of medical research. His work in the pharmaceutical industry has not only garnered multiple patents but has also contributed to the development of therapies that target complex health challenges associated with amyloid-related conditions.

Collaborations

Throughout his career, LeVine has collaborated with esteemed colleagues, including Sheryl Jeanne Hays and Jeffery David Scholten. This collaboration has fostered a dynamic exchange of ideas and innovation, aiding in the progression of their shared research goals.

Conclusion

Harry LeVine, III exemplifies the spirit of innovation in the field of biomedicine. With his groundbreaking patents and collaborative efforts, he signifies a commitment to advancing our understanding of amyloidosis and Alzheimer's disease, embodying the role of an impactful inventor in today's scientific landscape. His contributions not only highlight the importance of research but also emphasize the potential for innovation to improve lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…